XClose

UCL News

Home
Menu

Find out more about breast cancer research and treatment

24 October 2012

Do you want to know more about UCL's pioneering research into new diagnostic methods and treatment options for breast cancer? Do you want to see the latest cutting edge technologies used in breast cancer treatment at the Royal Free? If so, come along to our breast cancer public engagement event on Monday 29 October at 6.

Dr Mo Keshtgar 30-8pm in the Sir William Wells Atrium at the Royal Free Hospital.

The event, organised to mark breast cancer awareness month, will showcase some of the latest treatments and technologies being pioneered at UCL in partnership with the Royal Free.

This includes intra-operative radiotherapy (a treatment which means patients receive a single shot of radiotherapy during breast cancer surgery rather than having up to 30 hospital visits for post-operative radiotherapy), a new way of diagnosing and treating breast cancer with a flash of light, and minimally-invasive approaches to sentinel node surgery.

Visitors will also have a chance to learn about the role of diet in breast cancer and discover more about electrochemotherapy, a treatment which uses electrical pulses to stimulate cancer cells making them porous and more receptive to cancer-killing drugs.

There will also be an opportunity to learn about a new project which aims to improve communication with breast cancer patients.

The event will be interactive with demonstrations of the technologies. Mo Keshtgar, consultant oncological surgeon at the Royal Free and reader in cancer surgery at UCL, will start the event by giving an overview of the latest ground-breaking research and what is planned for the future.

Dr Keshtgar will also officially launch a new breast cancer awareness badge. The badges are being sold to raise money for the Royal Free Charity's breast cancer research fund.

There is no need to register for the event - just turn up on the evening.

-Ends-


Image caption: Mo Keshtgar, UCL researcher and Royal Free consultant.